Cancer therapy: Tumor suppressor p53 suppresses the expression of PTGS2 (prostaglandin-endoperoxide synthase 2) via up regulation of its target gene, 3/February/2014, 21.37

Therapeutic insights into the targeting of invasiveness of cancer cells: Tumor suppressor p53 suppresses the expression of UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GALNT7) via up regulation of its target gene, 3/February/2014, 21.18
February 3, 2014
Molecular Cancer therapy: The drug Metformin suppresses the expression of PTGS2 (prostaglandin-endoperoxide synthase 2) via up regulation of its target gene, 3/February/2014, 21.39
February 3, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Cancer therapy: Tumor suppressor p53 suppresses the expression of PTGS2 (prostaglandin-endoperoxide synthase 2) via up regulation of its target gene, 3/February/2014, 21.37, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.